Phase II evaluation of diaziquone (CI-904, AZQ) in the treatment of human malignant glioma-Reference-Cited by-同舟云学术

Phase II evaluation of diaziquone (CI-904, AZQ) in the treatment of human malignant glioma

Published:1985 Issue:3 Volume:3 Page:245-249
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neuro-Oncol

Author:

Maral J,Poisson M,Pertuiset BF,Mashaly P,Weill M,Jacquillat CI,Grillo-Lopez AJ

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Neurology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/BF00165185.pdf

Reference29 articles.

1. Driscoll JS, Hazard GF Jr, Wood HB Jr, Goldin A: Structure-antitumor activity relationships among quinone derivatives. Cancer Chemother Rep 4(2):1?363, 1974.

2. Driscoll JS: Aziridinylquinone antitumor agents. Chem Abst 87:194?230, 1977.

3. Corbett TH, Griswold DP: Degree and spectrum of anticancer agents in the sise colon cancer of mice (Abstract). Proc Am Ass Cancer Res 20:71, 1979.

4. Slagel DE, Feola J, Houchens DP, Ovejera AA: Combined modality treatment using radiation and/ or chemotherapy in an athymic nude mouse-human medulloblastoma and glioblastoma xenograft model. Cancer Res 42(3):812?816, 1982.

5. Kahn AH, Driscoll JS: Potential central nervous system antitumor agents. Aziridinylbenzoquinone. J Med Chem 19:213?317, 1976.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase I trial of lobradimil (RMP-7) and carboplatin in children with brain tumors;Cancer Chemotherapy and Pharmacology;2001-10-01

2. Prospects for bioreductive drug development;Expert Opinion on Investigational Drugs;1998-06

3. Preclinical phase II studies in human tumor xenografts: A European multicenter follow-up study;Annals of Oncology;1994-05

4. New agents in the treatment of primary brain tumors;Journal of Neuro-Oncology;1994

5. Neuro-oncology index and review (adult primary brain tumors);Journal of Neuro-Oncology;1991-10